MSMarie C. Smith

Marie C. Smith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marie C. Smith has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • John M. Davison

    School of Surgical and Reproductive Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; †Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico; and ‡Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, Florida

    2 shared publications
  • Alison P. Murdoch

    1 shared publication
  • Jm Davison

    Department of Obstetrics and Gynaecology, School of Surgical and Reproductive Sciences, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UK

    1 shared publication
  • John Davison

    School of Surgical and Reproductive Sciences, University of Newcastle upon Tyne, NE2 4HH, UK

    1 shared publication
  • Kirk Conrad

    Magee‐Womens Research Institute, Pittsburgh, Pensylvania 15213, USA

    1 shared publication
  • Kirk P. Conrad

    1 shared publication

Latest Publications

  • Assessment of glomerular filtration rate during pregnancy using the MDRD formula

    by MC Smith, P Moran, Mk Ward, Jm Davison

    It is now recommended practice to use estimated glomerular filtration rate (eGFR) values to screen for and monitor chronic renal disease. The most frequently used formula in the general population is that described following the Modification of Diet in Renal Disease (MDRD) study whereby serum creatinine is adjusted for age, gender and race. This study evaluates the performance of the MDRD formula in pregnancy by comparing eGFR with measured values obtained by inulin clearance studies in early and late normal pregnancy and in pregnancies complicated by renal disease or pre‐eclampsia. Our results indicate that in all situations, MDRD substantially underestimates glomerular filtration rate during pregnancy and cannot be recommended for use in clinical practice.


  • Influence of Recombinant Human Relaxin on Renal Hemodynamics in Healthy Volunteers

    by Marie C. Smith, Lee. A. Danielson, Kirk. P. Conrad, John M. Davison

    Maternal renal hemodynamic adaptation to human pregnancy is one of the most dramatic of all physiologic changes, but the factors that are responsible have remained elusive. In rat pregnancy, there are comparable renal hemodynamic changes, and in this species there is comprehensive evidence that the ovarian hormone relaxin (RLX) is responsible. This study investigated the renal effects of recombinant human RLX (rhRLX) in humans. Eleven volunteers (six male, five female) received intravenous infusions of rhRLX over 5 h at an infusion rate that was chosen to sustain serum concentrations that are comparable to early pregnancy. The renal clearances of inulin and para-aminohippurate were used to measure GFR and renal plasma flow, respectively. Irrespective of gender, renal plasma flow was increased by 47% compared with baseline levels (P < 0.0001), but no significant change was observed in GFR. There were no side effects or adverse reactions of rhRLX given as an intravenous infusion, and the data suggest that RLX indeed may be one of the elusive renal vasodilatory factors in human pregnancy. Further work is necessary to elucidate the complimentary factors that permit the concomitant increase in GFR during pregnancy.


  • Relaxin has a role in establishing a renal response in pregnancy

    by Marie C. Smith, Alison P. Murdoch, Lee A. Danielson, Kirk P. Conrad, John M. Davison


  • Renal Hemodynamic Effects of Relaxin in Humans

    by Marie Smith, John Davison, Kirk Conrad, Lee Danielson

    Rat studies have convincingly demonstrated the essential role of the ovarian hormone relaxin in mediating gestational renal hemodynamic and osmoregulatory changes in that species. We describe a model in nonpregnant volunteers using exogenous hCG to stimulate the production and release of ovarian relaxin in order to assess renal hemodynamic responses. Women (n= .0) were serially studied ± hCG stimulation during menstrual cycles with measurement of inulin, PAH, and neutral dextran clearances (to determine glomerular filtration rate [GFR], renal plasma flow [RPF], and glomerular porosity, respectively). Controls were women without ovarian function (n= 6) and men (n= .0). GFR and RPF were increased in the luteal phase compared to the follicular phase (15.3% increase in GFR, P <0.005; 17.8% increase in RPF, P <0.05). In controls, GFR and RPF were not significantly different between study occasions. Although exogenous hCG did not stimulate relaxin secretion in women without ovarian function or in men, it did so in normal women, but not into the pregnancy range. In no group were renal hemodynamics augmented by administered hCG. In naturally occurring cycles, increased serum relaxin is associated with augmented renal hemodynamics. As luteal stimulation with hCG failed to yield pregnancy relaxin levels, the use of exogenous relaxin for human administration is needed to further elucidate the renal vasodilatory properties of relaxin.